{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:51:43Z","timestamp":1783075903366,"version":"3.54.6"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,3,6]],"date-time":"2004-03-06T00:00:00Z","timestamp":1078531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1007\/s00213-004-1802-1","type":"journal-article","created":{"date-parts":[[2004,7,22]],"date-time":"2004-07-22T10:56:16Z","timestamp":1090493776000},"page":"148-153","source":"Crossref","is-referenced-by-count":18,"title":["A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration"],"prefix":"10.1007","volume":"175","author":[{"given":"Mirjam","family":"Talvik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels-Erik","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelija","family":"Jucaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"\u010cervenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Halldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Farde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,3,6]]},"reference":[{"key":"1802_CR1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/archneur.1993.00540050026010","volume":"50","author":"Antonini","year":"1993","unstructured":"Antonini A, Leenders KL, Reist H, Thomann R, Beer HF, Locher J (1993) Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride. Arch Neurol 50:474\u2013480","journal-title":"Arch Neurol"},{"key":"1802_CR2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archpsyc.1988.01800250095013","volume":"45","author":"Baldessarini","year":"1988","unstructured":"Baldessarini RJ, Cohen BM, Teicher MH (1988) Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry 45:79\u201391","journal-title":"Arch Gen Psychiatry"},{"key":"1802_CR3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","volume":"154","author":"Barnes","year":"1989","unstructured":"Barnes TRE (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672\u2013676","journal-title":"Br J Psychiatry"},{"key":"1802_CR4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00589893","volume":"99","author":"Baron","year":"1989","unstructured":"Baron JC, Martinot JL, Cambon H, Boulenger JP, Poirier MF, Caillard V, Blin J, Huret JD, Loc\u2019h C, Maziere B (1989) Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology 99:463\u2013472","journal-title":"Psychopharmacology"},{"key":"1802_CR5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00004728-198102000-00027","volume":"5","author":"Bergstr\u00f6m","year":"1981","unstructured":"Bergstr\u00f6m M, Bo\u00ebthius J, Eriksson L, Greitz T, Ribbe T, Wid\u00e9n L (1981) Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr 5:136\u2013141","journal-title":"J Comput Assist Tomogr"},{"key":"1802_CR6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0897-1897(95)80279-7","volume":"8","author":"Beyea","year":"1995","unstructured":"Beyea SC, Nicoll LH (1995) Administration of medications via the intramuscular route: an integrative review of the literature and research-based protocol for the procedure. Appl Nurs Res 8:23\u201333","journal-title":"Appl Nurs Res"},{"key":"1802_CR7","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1192\/bjp.151.6.824","volume":"151","author":"Cambon","year":"1987","unstructured":"Cambon H, Baron JC, Boulenger JP, Loc\u2019h C, Zarifian E, Maziere B (1987) In vivo assay for neuroleptic receptor binding in the striatum. Br J Psychiatry 151:824\u2013830","journal-title":"Br J Psychiatry"},{"key":"1802_CR8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/ajp.135.2.164","volume":"135","author":"Carlsson","year":"1978","unstructured":"Carlsson A (1978) Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 135:164\u2013173","journal-title":"Am J Psychiatry"},{"key":"1802_CR9","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1007\/BF00442559","volume":"99","author":"Casey","year":"1989","unstructured":"Casey DE (1989) Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology 99:S47\u201353","journal-title":"Psychopharmacology"},{"key":"1802_CR10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","volume":"192","author":"Creese","year":"1976","unstructured":"Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481\u2013483","journal-title":"Science"},{"key":"1802_CR11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2165\/00003088-198611010-00003","volume":"11","author":"Dahl","year":"1986","unstructured":"Dahl SG (1986) Plasma level monitoring of antipsychotic drugs. Clinical utility. Clin Pharmacokinet 11:36\u201361","journal-title":"Clin Pharmacokinet"},{"key":"1802_CR12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02244961","volume":"107","author":"Farde","year":"1992","unstructured":"Farde L (1992) Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans\u2014a PET study with [11C]SCH23390 and [11C]raclopride. Psychopharmacology 107:23\u201329","journal-title":"Psychopharmacology"},{"key":"1802_CR13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1192\/S0007125000296888","volume":"160","author":"Farde","year":"1992","unstructured":"Farde L, Nordstr\u00f6m A (1992) PET analysis indicates atypical central dopamine receptor occupancy in clozapine treated patients. Br J Psychiatry 160 (suppl 17):30\u201333","journal-title":"Br J Psychiatry"},{"key":"1802_CR14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.2867601","volume":"231","author":"Farde","year":"1986","unstructured":"Farde L, Hall H, Ehrin E, Sedvall G (1986) Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231:258\u2013261","journal-title":"Science"},{"key":"1802_CR15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF00212840","volume":"94","author":"Farde","year":"1988","unstructured":"Farde L, Pauli S, Hall H, Eriksson L, Halldin C, H\u00f6gberg T, Nilsson L, Sj\u00f6gren I, Stone-Elander S (1988a) Stereoselective binding of 11C-raclopride in living human brain\u2014a search for extrastriatal central D2-dopamine receptors by PET. Psychopharmacology 94:471\u2013478","journal-title":"Psychopharmacology"},{"key":"1802_CR16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1988.01800250087012","volume":"45","author":"Farde","year":"1988","unstructured":"Farde L, Wiesel F-A, Halldin C, Sedvall G (1988b) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45:71\u201376","journal-title":"Arch Gen Psychiatry"},{"key":"1802_CR17","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/jcbfm.1989.98","volume":"9","author":"Farde","year":"1989","unstructured":"Farde L, Eriksson L, Blomquist G, Halldin C (1989a) Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET\u2014a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9:696\u2013708","journal-title":"J Cereb Blood Flow Metab"},{"key":"1802_CR18","first-page":"32","volume":"7","author":"Farde","year":"1989","unstructured":"Farde L, Wiesel FA, Nilsson L, Sedvall G (1989b) The potential of positron-emission tomography for pharmacokinetic and pharmacodynamic studies of neuroleptics. Psychopharmacol Ser 7:32\u201339","journal-title":"Psychopharmacol Ser"},{"key":"1802_CR19","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1007\/BF00442555","volume":"99","author":"Farde","year":"1989","unstructured":"Farde L, Wiesel F-A, Nordstr\u00f6m A-L, Sedvall G (1989c) D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology 99:S28\u2013S31","journal-title":"Psychopharmacology"},{"key":"1802_CR20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","volume":"49","author":"Farde","year":"1992","unstructured":"Farde L, Nordstr\u00f6m A-L, Wiesel F-A, Pauli S, Halldin C, Sedvall G (1992) Positron emission tomographic analysis of central D1- and D2-dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine\u2014relation to extrapyramidal side effects. Arch Gen Psychiatry 49:538\u2013544","journal-title":"Arch Gen Psychiatry"},{"key":"1802_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00004714-198908000-00007","volume":"9","author":"Garver","year":"1989","unstructured":"Garver DL (1989) Neuroleptic drug levels and antipsychotic effects: a difficult correlation; potential advantage of free (or derivative) versus total plasma levels. J Clin Psychopharmacol 9:277\u2013281","journal-title":"J Clin Psychopharmacol"},{"key":"1802_CR22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s002130050492","volume":"135","author":"Gefvert","year":"1998","unstructured":"Gefvert O, Bergstrom M, Langstrom B, Lundberg T, Lindstrom L, Yates R (1998) Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia. Psychopharmacology 135:119\u2013126","journal-title":"Psychopharmacology"},{"key":"1802_CR23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0924-977X(00)00133-4","volume":"11","author":"Gefvert","year":"2001","unstructured":"Gefvert O, Lundberg T, Wieselgren IM, Bergstrom M, Langstrom B, Wiesel F, Lindstrom L (2001) D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study. Eur Neuropsychopharmacol 11:105\u2013110","journal-title":"Eur Neuropsychopharmacol"},{"key":"1802_CR24","unstructured":"Guy W (1976) Clinical Global Impressions ECDEU Assessment Manual for Psychopharmacology. ECDEU\u2014National Institute of Health, pp\u00a0218\u2013222"},{"key":"1802_CR25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.npp.1380111","volume":"11","author":"Hall","year":"1994","unstructured":"Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L (1994) Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11:245\u2013256","journal-title":"Neuropsychopharmacology"},{"key":"1802_CR26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00426481","volume":"53","author":"Hansen","year":"1977","unstructured":"Hansen LB, Larsen NE (1977) Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment. Psychopharmacology 53:127\u2013130","journal-title":"Psychopharmacology"},{"key":"1802_CR27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2125.1979.tb00900.x","volume":"7","author":"Hansen","year":"1979","unstructured":"Hansen LB, Elley J, Christensen TR, Larsen NE, Naestoft J, Hvidberg EF (1979) Plasma levels of perphenazine and its major metabolites during simultaneous treatment with anticholinergic drugs. Br J Clin Pharmacol 7:75\u201380","journal-title":"Br J Clin Pharmacol"},{"key":"1802_CR28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF00432245","volume":"78","author":"Hansen","year":"1982","unstructured":"Hansen LB, Larsen NE, Gulmann N (1982) Dose-response relationships of perphenazine in the treatment of acute psychoses. Psychopharmacology 78:112\u2013115","journal-title":"Psychopharmacology"},{"key":"1802_CR29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"Kane","year":"1988","unstructured":"Kane JM, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 45:789\u2013796","journal-title":"Arch Gen Psychiatry"},{"key":"1802_CR30","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1176\/ajp.153.7.948","volume":"153","author":"Kapur","year":"1996","unstructured":"Kapur S, Remington G, Jone C, Wilson A, DaSilva J, Houle S, Zipurski R (1996) High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am J Psychiatry 153:948\u2013950","journal-title":"Am J Psychiatry"},{"key":"1802_CR31","first-page":"286","volume":"156","author":"Kapur","year":"1999","unstructured":"Kapur S, Zipursky RB, Remington G (1999) Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 156:286\u2013293","journal-title":"Am J Psychiatry"},{"key":"1802_CR32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","volume":"157","author":"Kapur","year":"2000","unstructured":"Kapur S, Zipursky R, Jones C, Remington G, Houle S (2000a) Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 157:514\u2013520","journal-title":"Am J Psychiatry"},{"key":"1802_CR33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.57.6.553","volume":"57","author":"Kapur","year":"2000","unstructured":"Kapur S, Zipursky R, Jones C, Shammi CS, Remington G, Seeman P (2000b) A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry 57:553\u2013559","journal-title":"Arch Gen Psychiatry"},{"key":"1802_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02246046","volume":"119","author":"Karlsson","year":"1995","unstructured":"Karlsson P, Farde L, Halldin C, Sedvall G, Ynddal L, Sloth-Nielsen M (1995) Oral administration of NNC 756\u2014a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man. Psychopharmacology 119:1\u20148","journal-title":"Psychopharmacology"},{"key":"1802_CR35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"1802_CR36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0447.1985.tb08537.x","volume":"72","author":"Knudsen","year":"1985","unstructured":"Knudsen P, Hansen L, Auken G, Waehrens J, H\u00f8jholdt K, Larsen N-E (1985a) Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients. Acta Psychiatr Scand Suppl 72:15\u201328","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"1802_CR37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0447.1985.tb08537.x","volume":"1985","author":"Knudsen","year":"1985","unstructured":"Knudsen P, Hansen L, Auken G, Warens J, Hojholdt K, Larsen N-E (1985b) Efficacy and side effects in a 6 week double-blind comparative study of 50 drug monitored psychotic patients. Acta Psychiatr Scand 1985:15\u201328","journal-title":"Acta Psychiatr Scand"},{"key":"1802_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0447.1985.tb08538.x","volume":"72","author":"Knudsen","year":"1985","unstructured":"Knudsen P, Hansen L, H\u00f8jholdt K, Larsen N-E (1985c) Long-term depot neuroleptic treatment with perphenazine decanoate 1. Acta Psychiatr Scand Suppl 72:29\u201340","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"1802_CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0447.1985.tb08539.x","volume":"72","author":"Knudsen","year":"1985","unstructured":"Knudsen P, Hansen L, H\u00f8jholdt K, Larsen N-E (1985d) Long-term depot neuroleptic treatment with perphenazine decanoate 2. Acta Psychiatr Scand Suppl 72:41\u201350","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"1802_CR40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJM197602052940605","volume":"294","author":"Koch-Weser","year":"1976","unstructured":"Koch-Weser J, Sellers EM (1976a) Binding of drugs to serum albumin (first of two parts). N Engl J Med 294:311\u2013316","journal-title":"N Engl J Med"},{"key":"1802_CR41","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJM197603042941005","volume":"294","author":"Koch-Weser","year":"1976","unstructured":"Koch-Weser J, Sellers EM (1976b) Drug therapy. Binding of drugs to serum albumin (second of two parts). N Engl J Med 294:526\u2013531","journal-title":"N Engl J Med"},{"key":"1802_CR42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"Lammertsma","year":"1996","unstructured":"Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153\u2013158","journal-title":"Neuroimage"},{"key":"1802_CR43","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/00007691-198911000-00005","volume":"11","author":"Larsen","year":"1989","unstructured":"Larsen NE, Hansen LB (1989) Prediction of the optimal perphenazine decanoate dose based on blood samples drawn within the first three weeks. Ther Drug Monit 11:642\u2013646","journal-title":"Ther Drug Monit"},{"key":"1802_CR44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007691-198306000-00014","volume":"5","author":"Larsson","year":"1983","unstructured":"Larsson M, Forsman A (1983) A high-performance liquid chromatographic method for the assay of perphenazine and its dealkylated metabolite in serum after therapeutic doses. Ther Drug Monit 5:225\u2013228","journal-title":"Ther Drug Monit"},{"key":"1802_CR45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/hup.470070302","volume":"7","author":"Nordstr\u00f6m","year":"1992","unstructured":"Nordstr\u00f6m A-L, Farde L, Pauli S, Litton J-E, Halldin C (1992) PET analysis of central [11C]raclopride binding in healthy young adults and schizophrenic patients\u2014reliability and age effects. Hum Psychopharmacol 7:157\u2013165","journal-title":"Hum Psychopharmacol"},{"key":"1802_CR46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02251294","volume":"110","author":"Nordstr\u00f6m","year":"1993","unstructured":"Nordstr\u00f6m A-L, Farde L, Halldin C (1993a) High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET. Psychopharmacology 110:365\u2013367","journal-title":"Psychopharmacology"},{"key":"1802_CR47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-3223(93)90288-O","volume":"33","author":"Nordstr\u00f6m","year":"1993","unstructured":"Nordstr\u00f6m A-L, Farde L, Wiesel F-A, Forslund K, Pauli S, Halldin C, Uppfeldt G (1993b) Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects\u2014a double blind PET study of schizophrenic patients. Biol Psychiatry 33:227\u2013235","journal-title":"Biol Psychiatry"},{"key":"1802_CR48","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1176\/ajp.152.10.1444","volume":"152","author":"Nordstr\u00f6m","year":"1995","unstructured":"Nordstr\u00f6m A-L, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G (1995) D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiatry 152:1444\u20131449","journal-title":"Am J Psychiatry"},{"key":"1802_CR49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0925-4927(96)02921-6","volume":"67","author":"Nyberg","year":"1996","unstructured":"Nyberg S, Farde L, Halldin C (1996) Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients. Psychiatry Res 67:163\u2013171","journal-title":"Psychiatry Res"},{"key":"1802_CR50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S1461145798001229","volume":"1","author":"Nyberg","year":"1998","unstructured":"Nyberg S, Dencker SJ, Malm U, Dahl ML, Svenson JO, Halldin C, Naskashima Y, Farde L (1998) D(2)- and 5-HT(2) receptor occupancy in high-dose neuroleptic-treated patients. Int J Neuropsychopharmcol 1:95\u2013101","journal-title":"Int J Neuropsychopharmcol"},{"key":"1802_CR51","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1176\/ajp.137.12.1518","volume":"137","author":"Peroutka","year":"1980","unstructured":"Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137:1518\u20131522","journal-title":"Am J Psychiatry"},{"key":"1802_CR52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/jcbfm.1993.39","volume":"13","author":"Rinne","year":"1993","unstructured":"Rinne JO, Hietala J, Ruotsalainen U, Sako E, Laihinen A, Nagren K, Lehikoinen P, Oikonen V, Syvalahti E (1993) Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride. J Cereb Blood Flow Metab 13:310\u2013314","journal-title":"J Cereb Blood Flow Metab"},{"key":"1802_CR53","unstructured":"Ross EG (1985) Pharmacodynamics: mechanisms of drug action and the relationship between drug concentration and effect. In: Gilman AG, Rall L, Murad F (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp\u00a035\u201348"},{"key":"1802_CR54","unstructured":"Rowland MT (1995) Clinical pharmacokinetics concepts and applications, 3rd edn. Williams and Wilkins, Baltimore"},{"key":"1802_CR55","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","volume":"261","author":"Seeman","year":"1976","unstructured":"Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic\/dopamine receptors. Nature 261:717\u2013719","journal-title":"Nature"},{"key":"1802_CR56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"Simpson","year":"1970","unstructured":"Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212:11\u201319","journal-title":"Acta Psychiatr Scand"},{"key":"1802_CR57","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0006-3223(88)90048-0","volume":"23","author":"Smith","year":"1988","unstructured":"Smith M, Wolf A, Brodie J, Arnett C, Barouche F, Shiue C-Y, Fowler J, Russell J, MacGregor R, Wolkin A, Angrist B, Rotrosen J, Peselow E (1988) Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients. Biol Psychiatry 23:653\u2013663","journal-title":"Biol Psychiatry"},{"key":"1802_CR58","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0924-977X(02)00099-8","volume":"12","author":"Talbot","year":"2002","unstructured":"Talbot PS, Laruelle M (2002) The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development. Eur Neuropsychopharmacol 12:503\u2013511","journal-title":"Eur Neuropsychopharmacol"},{"key":"1802_CR59","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1176\/appi.ajp.158.6.926","volume":"158","author":"Talvik","year":"2001","unstructured":"Talvik M, Nordstr\u00f6m A-L, Nyberg S, Olsson H, Halldin C, Farde L (2001) No support for regional selectivity in clozapine-treated patients; a PET study with [11C]raclopride and [11C]FLB 457. Am J Psychiatry 158:926\u2013930","journal-title":"Am J Psychiatry"},{"key":"1802_CR60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00213-002-1082-6","volume":"162","author":"Tauscher","year":"2002","unstructured":"Tauscher J, Kufferle B, Asenbaum S, Tauscher-Wisniewski S, Kasper S (2002) Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol. Psychopharmacology 162:42\u201349","journal-title":"Psychopharmacology"},{"key":"1802_CR61","first-page":"492","volume":"160","author":"van","year":"1966","unstructured":"van Rossum JM (1966) The significance of dopamine receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn Ther 160:492\u2013494","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"1802_CR62","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/0006-2952(83)90019-9","volume":"32","author":"Verbeeck","year":"1983","unstructured":"Verbeeck RK, Cardinal JA, Hill AG, Midha KK (1983) Binding of phenothiazine neuroleptics to plasma proteins. Biochem Pharmacol 32:2565\u20132570","journal-title":"Biochem Pharmacol"},{"key":"1802_CR63","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004728-199401000-00023","volume":"18","author":"Wienhard","year":"1994","unstructured":"Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, Heiss W (1994) The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 18:110\u2013118","journal-title":"J Comput Assist Tomogr"},{"key":"1802_CR64","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0893-133X(02)00304-4","volume":"27","author":"Yokoi","year":"2002","unstructured":"Yokoi F, Grunder G, Biziere K, Stephane M, Dogan AS, Dannals RF, Ravert H, Suri A, Bramer S, Wong DF (2002) Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Neuropsychopharmacology 27:248\u2013259","journal-title":"Neuropsychopharmacology"},{"key":"1802_CR65","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/jps.2600640710","volume":"64","author":"Zia","year":"1975","unstructured":"Zia H, Price JC (1975) Binding study of sulfonylureas and phenothiazines to bovine serum albumin using difference spectrophotometry. J Pharm Sci 64:1177\u20131181","journal-title":"J Pharm Sci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-1802-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-004-1802-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-1802-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T20:38:13Z","timestamp":1585859893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-004-1802-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,6]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["1802"],"URL":"https:\/\/doi.org\/10.1007\/s00213-004-1802-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,6]]}}}